Considering that wild‐type EGFR downstream pathways could upregulate ERCC1 expression, we question whether the aberrant signals raised by mutant EGFR contribute to downregulation of ERCC1 in mutant EGFR NSCLC cells. This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.